Inflammatory events at the blood brain barrier: Regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species

Brain, Behavior, and Immunity

Volumn 11, Issue 4, 1997, Pages 245-263

  Merrill, Jean E ^a   Murphy, Seán P ^b  

^a BAYER AG   (Germany)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Adhesion molecules; Blood brain barrier; Chemokines; CNS genes; Cytokines; EAE; MS; Nitric oxide; Oxygen radicals; Psychoneuroimmunology

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYCLIC AMP; CYTOKINE; NITRIC OXIDE; NITROGEN; PROSTANOID; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNE DISEASE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; HUMAN; INFECTION; INFLAMMATORY CELL; LEUKOCYTE ADHERENCE; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVE INJURY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0031424783     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1006/brbi.1997.0496     Document Type: Review

References (165)

1. Akarasereenont, P., Mitchell, J. A., Bakhle, Y. S., Thiemermann, C., & Vane, J. R. (1995). Comparison of the induction of cyclooxygenase and nitric oxide synthase by endotoxin in endothelial cells and macrophages. Eur. J. Pharmacol. 272, 121-128.
2. Akassoglou, K., Probert, L., Konogeorgos, G., & Kollias, G. (1997). Astrocyte-specific nut not neuron-specific transmembrane TNF triggers inflammation and degeneration in the CNS of transgenic mice. J. Immunol. 158, 438-445.
3. Alleva, D. G., Burger, C. J., & Elgert, K. D. (1994). Tumor-induced regulation of suppressor macrophage nitric oxide and TNFα production. Role of tumor-derived IL-10, TGFβ, and prostaglandin E2. J. Immunol. 153, 1674-1686.
4. Alonso, A., Carvalho, J., Alonso-Torre, S. R., Nunez, L., Bosca, L., & Crespo, M. S. (1995). Nitric oxide synthesis in rat peritoneal macrophages is induced by IgE/DNP complexes and cyclic AMP analogues. Evidence in favor of a common signaling mechanism. J. Immunol. 154, 6475-6483.
5. Andrew, P. J., Harant, H., & Lindley, I. J. D. (1995). Nitric oxide regulates IL-8 expression in melanoma cells at the transcriptional level. Biochem. Biophys. Res. Commun. 214, 949-956.
6. Appelberg, R. (1995). Opposing effects of Interleukin-10 on mouse macrophage functions. Scand. J. Immunol. 41, 539-544.
7. Baeuerle, P. A., & Henkel, T. (1994). Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12, 141-179.
8. Bagasra, O., Michaels, F. H., Zheng, Y. M., Bobroski, L. E., Spitsin, S. V., Fu, Z. F., Tawadros, R., & Koprowski, H. (1995). Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA 92, 12041-12045.
9. Baron, J. L., Madri, J. A., Ruddle, N. H., Hashim, G., & Janeway, C. A. (1993). Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177, 57-68.
10. Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997). Nature 385, 640-644.
11. Bauer, M. K., Lieb, K., Schulze-Osthoff, K., Berger, M., Gebicke-Haerter, P. J., Bauer, J., & Fiebich, B. L. (1997). Expression and regulation of cyclooxygenase-2 in rat microglia. Eur. J. Biochem. 243, 726-731.
12. Becherel, P. A., Mossalayi, M. D., Le-Goff, L., Ouaaz, F., Dugas, B., Guillosson, J. J., Debre, P., & Arock, M. (1994). IgE-dependent activation of Fce RII/CD23+ normal human keratinocytes: The role of cAMP and nitric oxide. Cell. Mol. Biol. 40, 283-290.
13. Bereta, J., Cohen, M. C., & Bereta, M. (1995). Stimulatory effects of oubain on VCAM-1 and iNOS expression in murine endothelial cells: involvement of NF-κB. FEBS Lett. 377, 21-25.
14. Bianchi, M., Fantuzzi, G., Bertini, R., Perin, L., Salmona, M., & Ghezzi, P. (1993). The pneumotoxicant paraquat induces IL-8 mRNA in human mononuclear cells and pulmonary epithelial cells. Cytokine 5, 525-530.
15. + T cells. J. Immunol. 158, 3046-3053.
16. Biswas, D. K., Dezube, B. J., Ahlers, C. M., & Pardee, A. B. (1993). Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-κB action. J. AIDS 6, 778-786.
17. Bö, L., Dawson, T. M., Wesselingh, S., Mork, S., Choi, S., Kong, P. A., Hanley, D., & Trapp, B. D. (1995). Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36, 778-786.
18. Bogdan, C., Vodovotz, Y., Paik, J., Xie, Q-W., & Nathan, C. (1994). Mechanisms of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J. Leukocyte Biol. 55, 227-233.
19. Boullerne, A. I., Petry, K. G., Meynard, M., & Geffard, M. (1995). Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine. J. Neuroimmunol. 60, 117-124.
20. Boutard, V., Havouis, R., Fouqueray, B., Philippe, C., Moulinoux, J-P., & Baud, L. (1995). Transforming growth factor-b stimulates arginase activity in macrophages. J. Immunol. 155, 2077-2084.
21. Bö, L., Dawson, T. M., Wesselingh, S., Mork, S., Choi, S., Kong, P. A., Hanley, D., & Trapp, B. D. (1995). Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36, 778-786.
22. Breder, C. D., Smith, W. L., & Raz, A. (1992). Distribution and characterization of cyclooxygenase activity in the ovine brain. J. Comp. Neurol. 322, 409-438.
23. Breder, C. D., deWitt, D., & Kraig, R. P. (1995). Characterization of inducible cyclooxygenase in rat brain. J. Comp. Neurol. 355, 296-315.
24. Brenner, T., Brocke, S., Szafer, F., Sobel, R. A., Parkinson, J. F., Perez, D. H., & Steinman, L. (1997). Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J. Immunol. 158, 2940-2946.
25. Brian, J. E., Heistad, D. D., & Faraci, F. M. (1995). Mechanisms of endotoxin-induced dilatation of cerebral arterioles. Am. J. Physiol. 269, H783-788.
26. Bulut, V., Severn, A., & Liew, F. Y. (1993). Nitric oxide production by murine macrophages is inhibited by prolonged elevation of cyclic AMP. Biochem. Biophys. Res. Commun. 195, 1134-1138.
27. Cannella, B., Gao, Y. L., Brosnan, C., & Raine, C. S. (1996). IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45, 735-746.
28. Cao, C., Matsumuta, K., Yamagata, K., & Watanabe, Y. (1995). Induction by lipopolysaccharide of COX-2 mRNA in rat brain. Brain Res. 697, 187-196.
29. Cash, E., Minty, A., Ferrara, P., Caput, D., Fradelizi, D., & Rott, O. (1994). Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J. Immunol. 153, 4258-4267.
30. Chao, C. C., Molitor, T. W., & Hu, S. (1993). Neuroprotective role of IL-4 against activated microglia. J. Immunol. 151, 1473-1481.
31. Chen, J., Marsh, T., Zhang, J. S., & Graham, S. H. (1995). Expression of COX-2 in rat brain following kainate treatment. Mol. Neurosci. 6, 245-248.
32. Chesrown, S. E., Monnier, J., Visner, G., & Nick, H. S. (1994). Regulation of inducible nitric oxide synthase mRNA levels by LPS, IFN γ, TGF-β, and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochem. Biophys. Res. Commun. 200, 126-134.
33. Cross, A. H., Misko, T. P., Lin, R. F., Hickey, W. F., Trotter, J. L., & Tilton, R. G. (1994). Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93, 2684-2690.
34. Cunha, F. Q., Moncada, S., & Liew, F. Y. (1992). Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-g in murine macrophages. Biochem. Biophys. Res. Commun. 182, 1155-1159.
35. De Caterina, R., Libby, P., Peng, H-B., Thannickal, V. J., Rajavshisth, T. B., Gimbrone, M. A., Jr., Shin, W. S., & Liao, J. K. (1995). Nitric oxide decreases cytokine-induced endothelial activation. J. Clin. Invest. 96, 60-68.
36. DeForge, L. E., Fantone, J. C., Kenney, J., & Remick, D. G. (1992). Oxygen radical scavengers selectively inhibit interleukin 8 production in human whole blood. J. Clin. Invest. 90, 2123-2129.
37. DeForge, L. E., Preston, A. M., Takeuchi, E., Kenney, J., Boxer, L. A., & Remick, D. G. (1993). Regulation of interleukin 8 gene expression by oxidant stress. J. Biol. Chem. 268, 25568-25576.
38. De Groot, C. J. A., Ruuls, S. R., Theeuwes, J. W. M., Dijkstra, C. D., & Van der Walk, P. (1997). Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 56, 10-20.
39. Del Pozo, M., Sanchez-mateos, P., Nieto, M., & Sanchez-Madrid-F. (1995). Chemokines regulate cellular polarization and adhesion receptor redistribution during lymphocyte interaction with endothelium and extracellular matrix: Involvement of cAMP signalling pathway. J. Cell Biol. 131, 495-506.
40. DeWitt, D. L., & Meade, E. A. (1993). Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and -2 isozymes. Arch. Biochem. Biophys. 306, 94-102.
41. Ding, A., Nathan, C. F., Graycar, J., Derynck, R., Stuehr, D. J., & Srimal, S. (1990). Macrophage deactivating factor and transforming growth factors-β1, -β2, -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFNγ. J. Immunol. 145, 940-944.
42. Dröge, W., Schulze-Osthoff, K., Mihm, S., Galter, D., Schenk, H., Eck, H-P., Roth, S., & Gmünder, H. (1994). Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J. 8, 1131-1138.
43. East, C. J., Abboud, C. N., & Borch, R. F. (1992). Diethyldithiocarbamate induction of cytokine release in human long-term bone marrow cultures. Blood 80, 1172-1177.
44. Eigler, A., Sinha, B., & Endres, S. (1993). Nitric oxide-releasing agents enhance cytokine-induced tumor necrossi factor synthesis in human mononuclear cells. Biochem. Biophys. Res. Commun. 196, 494-501.
45. Farivar, R. S., Chobanian, A. V., & Brecher, P. (1996). Salicylate or aspirin inhibits the induction of the inducible nitric oxide synthase in rat cardiac fibroblasts. Circ. Res. 78, 759-768.
46. Feinstein, D. L., Galea, E., & Reis, D. J. (1993). Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures. J. Neurochem. 60, 1945-1948.
47. Feng, L., Sun, W., Xia, Y., Tang, W. W., Chanmugam, P., Soyoola, E., Wilson, C. B., & Hwang, D. (1993). Cloning two isoforms of rat cyclooxygenase. Arch. Biochem. Physiol. 307, 361-368.
48. Feng, L., Xia, Y., Garcia, G. E., Hwang, D., & Wilson, C. B. (1995). Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-a, and lipopolysaccharide. J. Clin. Invest. 95, 1669-1675.
49. Fülle, H-J., Enders, S., Sinha, B., Stoll, D., Weber, P. C., & Gerzer, R. (1991). Effects of SIN-1 on cytokine synthesis in human mononuclear cells. J. Cardiovasc. Pharmacol. 17, S113-S116.
50. Gazzinelli, R. T., Oswald, I. P., Hieny, S., James, S. L., & Sher, A. (1992). The microbicidal activity of interferon-g-treated macrophages against Trypansoma cruzi involves L-arginine-dependent nitrogen-oxide-mediated mechanism inhibitable by interleukin 10 and transforming growth factor-b. Eur. J. Immunol. 22, 2501-2512.
51. Genain, C. P., Roberts, T., Davis, R. L., Nguyen, M-H., Uccelli, A., Faulds, D., Li, Y., Hedgpeth, J., & Hauser, S. L. (1995). Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc. Natl. Acad. Sci. USA 92, 3601-3605.
52. Gerritsen, M. E., & Bloor, C. M. (1993). Endithelial cell gene expression in response to injury. FASEB J. 7, 523-532.
53. Ghirnikar, R. S., Lee, Y. L., He, T. R., & Eng, L. F. (1996). Chemokine expression in rat stab wound brain injury. J. Neurosci. Res. 46, 727-733.
54. Glabinski, A. R., Tani, M., Stieter, R. M., Tuohy, V. K., & Ransohoff, R. M. (1997). Synchronous synthesis of a and b-chemokines by cells of diverse lineage in the CNS of mice with relapses of chronic EAE. Am. J. Pathol. 150, 617-630.
55. Goodall, C. A., Curtis, A. S. G., & Lang, S. C. (1992). Modulation of adhesion of lymphocytes to murine brain endothelial cells in vitro: Relation to class II major histocompatibility complex expression. J. Neuroimmunol. 37, 9-22.
56. Grau, V., Herbst, B., Van Der Meide, P. H., & Steiniger, B. (1997). Activation of microglial and endothelial cells in the rat brain after treatment with interferon-gamma in vivo. Glia 19, 181-189.
57. Guy, J., McGorray, S., Fitzsimmons, J., Beck, B., & Rao, N. A. (1994). Disruption of the blood-brain barrier in experimental optic neuritis. Invest. Opthalmol. Vis. Sci. 35, 1114-1123.
58. Hall, G. L., Compston, A., & Scolding, N. J. (1997). Beta-interferon and multiple sclerosis. Trends Neurosci. 20, 63-67.
59. Hartung, H-P., Schäfer, B., Heininger, K., & Toyka, K. (1988). Suppression of experimental autoimmune neuritis by the oxygen radical scavengers superoxide dismutase and catalase. Ann. Neurol. 23, 453-460.
60. Hausmann, E. H., Hao, S. Y., Pace, J. L., & Parmely, M. J. (1994). Transforming growth factor beta 1 and gamma interferon provide opposing signals to lipopolysaccharide-activated mouse macrophages. Infect. Immun. 62, 3625-3632.
61. Heuschling, P. (1995). Nitric oxide modulates g-interferon-induced MHC class II antigen expression on rat astrocytes. J. Neuroimmunol. 57, 63-69.
62. Hofman, F. M., Hinton, D. R., Johnson, K., & Merrill, J. E. (1989). Tumor necrosis factor identified in multiple sclerosis brain. J. Exp. Med. 170, 607-612.
63. Hofman, F. M., von Hanwehr, R. I., Dinarello, C. A., Mizel, S. B., Hinton, D., & Merrill, J. E. (1986). Immunoregulatory molecules and IL2 receptors identified in multiple sclerosis brain. J. Immunol. 136, 3239-3245.
64. Hooper, D. C., Ohnishi, S. T., Kean, R., Numagami, Y., Dietzschold, B., & Koprowski, H. (1995). Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc. Natl. Acad. Sci. USA 92, 5312-5316.
65. Huitinga, I., van Rooijen, N., de Groot, C. J. A., Uitdehaag, B. M. J., & Dijkstra, C. D. (1990). Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J. Exp. Med. 172, 1025-1034.
66. Hulkower, K., Brosnan, C. F., Aquino, D. A., Cammer, W., Kulshrestha, S., Guida, M. P., Rapoport, D. A., & Berman, J. W. (1993). Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J. Immunol. 150, 2525-2533.
67. Huynh, H. K., Oger, J., & Dorovini-Zis, K. (1995). Interferon-β downregulates interferon-g-induced class II MHC molecule expression and morphological changes in primary cultures of human brain microvessel endothelial cells. J. Neuroimmunol. 60, 63-73.
68. Johnson, A. W., Land, J. M., Thompson, E. J., Bolanos, J. P., Clark, J. B., & Heales, S. J. (1995). Evidence for increased nitric oxide production in multiple sclerosis. J. Neurol. Neurosurg. Psych. 58, 107-116.
69. Kanno, K., Hirata, Y., Imai, T., Iwashina, M., & Marumo, F. (1994). Regulation of inducible nitric oxide synthase gene by interleukin-1 b in rat vascular endothelial cells. Am. J. Physiol. 267, H2318-H2324.
70. Karpus, W. J., Lukacs, N. W., McRae, B. L., Strieter, R. M., Kunkel, S. L., & Miller, S. D. (1995). An important role for the chemokine macrophage inflammatory protein-1a in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J. Immunol. 155, 5003-5010.
71. Khan, B., Harrison, D. G., Olbrych, M. T., Alexander, R. W., & Medford, R. M. (1996). Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc. Natl. Acad. Sci. USA 93, 9114-9119.
72. Khoury, S. J., Hancock, W. W., & Weiner, H. L. (1992). Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation transforming growth factor b, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176, 1355-1364.
73. Koprowski, H., Zheng, Y. M., Heber-Katz, E., Fraser, N., Rorke, L., Fu, Z. F., Hanlon, C., & Dietzschold, B. (1993). In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc. Natl. Acad. Sci. USA 90, 3024-3027.
74. Koyama, Y., Tanaka, Y., Saito, K., Abe, M., Nakatsuka, K., Morimotto, I., Aurion, P.E., & Eto, S. (1996). Cross-linking of intercellular adhesion molecule-1 (CD54) induces AP-1 activation and IL-1β transcription. J. Immunol. 157, 5097-5103.
75. Kozaki, K., Egawa, H., Bermudes, L., Feduska, N. J., So, S., & Esquivel, C. O. (1993). Pentoxifylline inhibits production of superoxide anion and tumor necrosis factor by kupffer cells in rat liver preservation. Transplant. Proc. 25, 3025-3026.
76. Li, L., Elliott, J. F., & Mosmann, T. R. (1994). IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J. Immunol. 153, 3967-3978.
77. Lieb, K., Kaltschmidt, C., Kaltschmidt, B., Baeuerle, P. A., Berger, M., Bauer, J., & Fiebich, B. L. (1996). Interleukin-1β uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor a genes in the human astrocytoma cell line U373. J. Neurochem. 66, 1496-1503.
78. Lin, R., Lin, T-S., Tilton, R. G., & Cross, A. H. (1993). Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: An electron paramagnetic resonance study. J. Exp. Med. 178, 643-648.
79. Mackenzie-Graham, A. J., Mitrovic, B., Smoll, A., & Merrill, J. E. (1994). Differential sensitivity to nitric oxide in immortalized, cloned murine oligodendrocyte cell lines. Dev. Neurosci. 16, 162-171.
80. MacMicking, J. D., Nathan, C., Holm, G., Chartain, N., Fletcher, D. S., Trumbauer, M., Stevens, K., Xie, Q-W., Sokol, K., Hutchinson, N., Chen, H. G., & Mudgett, J. S. (1995). Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81, 641-650.
81. MacMicking, J. D., Willenborg, D. O., Weidemann, M. J., Rockett, K. A., & Cowden, W. B. (1992). Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalitis: Enhancement by the soluble products of encephalitogenic T cells. J. Exp. Med. 176, 303-307.
82. MacMillan-Crow, L. A., Crow, J. P., Kerby, J. D., Beckman, J. S., & Thompson, J. A. (1996). Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc. Natl. Acad. Sci. USA 93, 11853-11858.
83. Magrinat, G., Mason, S. N., Shami, P. J., & Weinberg, J. B. (1992). Nitric oxide modulation of human leukemia cell differentiation and gene expression. Blood 80, 1880-1884.
84. Marcinkiewicz, J., Grabowska, A., & Chain, B. (1995). Nitric oxide upregulates the release of inflammatory mediators by mouse macrophages. Eur. J. Immunol. 25, 947-951.
85. Marotta, P., Sautebin, L., & DiRosa, M. (1992). Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br. J. Pharmacol. 107, 640-641.
86. Marui, N., Offermann, M. K., Swerlick, R., Kunsch, C., Rosen, C. A., Ahmad, M., Alexander, R. W., & Medford, R. M. (1993). Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92, 1866-1874.
87. Masuyama, J-I., Minato, N., & Kano, S. (1986). Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. J. Clin. Invest. 77, 1596-1605.
88. Mautino, G., Paul-Eugene, N., Chanez, P., Vignola, A. M., Kolb, J. P., Bousquet, J., & Dugas, B. (1994). Heterogeneous spontaneous and interleukin-4-induced nitric oxide production by human monocytes. J. Leukocyte Biol. 56, 15-20.
89. Mayhan, W. G. (1996). Role of nitiric oxide in histamine-induced increases in permeability of the blood-brain barrier. Brain Res. 743, 70-76.
90. McLaurin, J., Antel, J. P., & Yong, V. W. (1995). Immune and non-immune actions of interferon-b-1b on primary human neural cells. Multiple Sclerosis 1, 10-19.
91. Meda, L., Bernasconi, S., Bonaiuto, C., Sozzani, S., Zhou, D., Otvos, L., Mantovani, A., Rossi, F., & Cassatella, M. A. (1996). β-amyloid (25-35) peptide and IFN-γ synergistically induce the production of the chemotactic cytokine MCP-1/JE in monocytes and microglial cells. J. Immunol. 157, 1213-1218.
92. Merrill, J. E., Howard, B. D., & Maidment, N. T. (1996). HIV-1 env and glutamate induction of NO, IL1, and TNF. In G. Jeserich & H. H. Althaus (Eds.), Molecular signaling and regulation in glial cells: A key to remyelination and functional repairs, pp. 57-68. Springer-Verlag: Heidelberg.
93. Merrill, J. E., & Murphy, S. P. (1997). Regulation of gene expression in the nervous system by reactive oxygen and nitrogen species. Met. Brain Dis. 12, 97-112.
94. Merrill, J. E., & Benveniste, E. N. (1996). Cytokines in inflammatory brain lesions: Helpful and harmful. Trends Neurosci. 19, 331-338.
95. Merrill, J. E., & Murphy, S. (1996). Nitric oxide. In M. Aschner & H. K. Kimelberg (Eds.), The role of glia in neurotoxicity, pp. 263-281. New York: CRC Press.
96. Merrill, J. E., Graves, M. C., & Mulder, D. G. (1992a). Autoimmune disease of the nervous system: Biochemical, molecular, and clinical update. West. J. Med. 156, 639-646.
97. Merrill, J. E., Kono, D. H., Clayton, J., Ando, D. G., Hinton, D. R., & Hofman, F. M. (1992b). Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. USA 89, 574-578.
98. Merrill, J. E., Strom, S. R., Ellison, G. W., & Myers, L. W. (1989). In vitro study of mediators of inflammation in multiple sclerosis. J. Clin. Immunol. 9, 84-96.
99. Merrill, J. E., Ignarro, L. J., Sherman, M. P., Melinek, J., & Lane, T. E. (1993). Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151, 2132-2141.
100. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12, 2005-1013.
101. Miller, A., Lanir, N., Shapiro, S., Revel, M., Honigman, S., Kinarty, A., & Lahat, N. (1996). Immunoregulatory effects of interferon β and interacting cytokines on human vascular endothelial cells: Implications for multiple sclerosis and other autoimmune diseases. J. Neuroimmunol. 64, 151-161.
102. Miyagishi, R., Kikuchi, S., Fukazawa, T., & Tashiro, K. (1995). Macrophage inflammatory protein-1a in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological diseases. J. Neurol. Sci. 129, 223-227.
103. Muñoz, C., Castellanos, M. C., Alfranca, A., Vara, A., Esteban, M. A., Redondo, J. M., & de Landázuri, M. O. (1996). Transcriptional up-regulation of intercellular adhesion molecule-1 in human endothelial cells by the antioxidant pyrrolidine dithiocarbamate involves the activation of activating protein-1. J. Immunol. 157, 3587-3597.
104. Murphy, S., & Grzybicki, D. (1996). Glial NO: Normal and pathological roles. Neuroscientist 2, 90-99.
105. Murphy, S., Grzybicki, D. M., & Simmons, M. L. (1995). Glial cells as nitric oxide sources and targets. In S. Vincent (Ed.), Nitric oxide in the nervous system, pp. 164-190. San Diego: Academic Press.
106. Murphy, S., Simmons, M. S., Agullo, L., Garcia, A., Feistein, D. L., Gallea, E., Reis, D. L., Minc-Golomb, D., & Schwartz, J. P. (1993). Synthesis of nitric oxide in CNS glial cells. Trends Neurosci. 16, 323-328.
107. Nogawa, S., Zhang, F., Ross, M. E., & Iadelcola, C. (1997). Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage. J. Neurosci. 17, 2746.
108. Noiri, E., Hu, Y., Bahou, W. F., Keese, C. R., Giaver, I., & Goligorsky, M. S. (1997). Permissive role of nitric oxide in endothelin-induced migration of endothelial cells. J. Biol. Chem. 272, 1747-1752.
109. Okuda, Y., Nakatsuji, Y., Fujimura, H., Esumi, H., Ogura, T., Yanagihara, T., & Sakoda, S. (1995). Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62, 103-12.
110. Oswald, I. P., Gazzinelli, R. T., Sher, A., & James, S. L. (1992). IL-10 synergizes with IL-4 and transforming growth factor-b to inhibit macrophage cytotoxic activity. J. Immunol. 148, 3578-3582.
111. Pang, L., & Hoult, J. R. S. (1997). Repression of inducible nitric oxide synthase and cyclooxygenase-2 by prostaglandin E2 and other cyclic AMP stimulants in J774 macrophages. Biochem. Pharmacol. 53, 493-500.
112. Park, S. K., Lin, H. L., & Murphy, S. (1994). Nitric oxide limits transcriptional induction of nitric oxide synthase in CNS glial cells. Biochem. Biophys. Res. Commun. 201, 762-768.
113. Park, S. K., Lin, H. L., & Murphy, S. (1997). Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-κB binding to DNA. Biochem. J. 322, 609-613.
114. Parkinson, J. F., Mitrovic, B., & Merrill, J. E. (1996). The role of nitric oxide in multiple sclerosis. J. Mol. Med. 75, 174-186.
115. Paul-Eugene, N., Kolb, J-P., Damais, C., Yamaoka, K., & Dugas, B. (1994). Regulatory role of nitric oxide in the IL-4-induced IgE production by normal human peripheral blood mononuclear cells. Lymphokine Cytokine Res. 13, 287-293.
116. Paul-Eugene, N., Kolb, J. P., Damais, C., & Dugas, B. (1994). Heterogeneous nitrite production by IL-4 stimulated human monocytes and peripheral blood mononuclear cells. Immunol. Lett. 42, 31-34.
117. Paul-Eugene, N., Pene, J., Bousquet, J., & Dugas, B. (1995). Role of cyclic nucleotides and nitric oxide in blood mononuclear cell IgE production stimulated by IL-4. Cytokine 7, 64-69.
118. Peng, H-B., Rajavashidsth, T. B., Libby, P., & Liao, J. K. (1995a). Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J. Biol. Chem. 270, 17050-17055.
119. Peng, H., Libby, P., & Liao, J. K. (1995b). Induction and stabilization of IkBa by nitric oxide mediates inhibition of NF-κB. J. Biol. Chem. 270, 14214-14219.
120. Peterson, P. K., Hu, S., Salak-Johnson, J., Molitor, T. W., & Chao, C. C. (1997). Differential production of and migratory response to b chemokines by human microglia and astrocytes. J. Infect. Dis. 175, 478-481.
121. Raes, M., Renard, P., & Remacle, J. (1995). Free radicals as second messengers. C. R. Soc. Biol. 189, 355-366.
122. Ransohoff, R. M., Devajyothi, C., Estes, M. L., Babcock, G., & Rudick, R. A. (1991). Interferon-b specifically inhibits interferon-g-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line. J. Neuroimmunol. 33, 103-112.
123. Ransohoff, R. M., Glabinski, A., & Tani, M. (1996). Chemokines in immune-mediated inflammation of the central nervous system. Cytokine Growth Factor Rev. 7, 35-46.
124. Remick, D. G., & Villarete, L. (1996). Regulation of cytokine gene expression by reactive oxygen and reactive nitrogen intermediates. J. Leukocyte Biol. 59, 471-475.
125. Rodriguez, M., Pavelko, K. D., McKinney, C. W., & Leibowitz, J. L. (1994). Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. J. Immunol. 153, 3811-3821.
126. Romani, L., Puccetti, P., Menacci, A., Cenci, E., Spaccapelo, R., Tonnetti, L., Grohmann, U., & Bistoni, F. (1994). Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J. Immunol. 152, 3514-3521.
127. Rose, L. M., Richards, T., & Alvord, E. C. (1994). Experimental allergic encephalomyelitis (EAE) in nonhuman primates: A model of multiple sclerosis. Lab. An. Sci. 44, 508-511.
128. Rosasi, D. L., Vicari, A. P., Franz-Bacon, K., McClanahan, T. K., & Zlotnik, A. (1997). Identification through bioinformatics of two new macrophage proinflammatory human chemokines. J. Immunol. 158, 1033-1036.
129. Rothe, H., Hartmann, B., Geerlings, P., & Kolb, H. (1996). Interleukin-12 gene expression of macrophages is regulated by nitric oxide. Biochem. Biophys. Res. Commun. 224, 159-163.
130. Ruuls, S. R., Van Der Linden, S., Sontrop, K., Huitinga, I., & Dijkstra, C. D. (1996). Aggravation of experimental allergic encephalomyelitis by administration of nitric oxide synthase inhibitors. Clin. Exp. Immunol. 103, 467-476.
131. Salvemini, D., Misko, T. P., Masferrer, J. L., Seibert, K., Currie, M. G., & Needleman, P. (1993). Nitric oxide activates cyclooxygenase enzymes. Proc. Natl. Acad. Sci. USA 90, 7240-7244.
132. Sands, W. A., Bulut, V., Severn, A., Xu, D., & Liew, F. Y. (1994). Inhibition of nitric oxide synthase by interleukin-4 may involve inhibiting the activation of protein kinase C. Eur. J. Immunol. 24, 2345-2350.
133. Satriano, J. A., Shuldiner, M., Hora, K., Xing, Y., Shan, Z., & Schlondorff, D. (1993). Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor a and immunoglobulin G. J. Clin. Invest. 92, 1564-1571.
134. Schenk, H., Vogt, M., Droge, W., & Schulze-Osthoff, K. (1996). Thioredoxin as a potent costimulus of cytokine expression. J. Immunol. 156, 765-771.
135. Schneemann, M., Schoedon, G., Frei, K., & Schaffner, A. (1993). Immunovascular communication: Activation and deactivation of murine endothelial cell nitric oxide synthase by cytokines. Immunol. Lett. 35, 159-162.
136. Schulze-Osthoff, K., Beyaert, R., Vandevoorde, V., Haegeman, G., & Fiers, W. (1993). Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 12, 3095-3104.
137. Segal, B. M., & Shevach, E. M. (1996). IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med. 184, 771-775.
138. Shin, W. S., Hong, Y-H., Peng, H-B., De Caterina, R., Libby, P., & Liao, J. K. (1996). Nitric oxide attenuates vascular smooth muscle cell activation by interferon-γ. J. Biol. Chem. 271, 11317-11324.
139. Sicher, S. C., Chung, G. W., Vazquez, M. A., & Lu, C. Y. (1995). Augmentation or inhibition of IFN-γ-induced MHC class II expression by lipopolysaccharides. J. Immunol. 155, 5826-5834.
140. Sicher, S. C., Vazquez, M. A., & Lu, C. Y. (1994). Inhibition of macrophage Ia expression by nitric oxide. J. Immunol. 153, 1293-1300.
141. Simonian, N. A., & Coyle, J. T. (1996). Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 36, 83-106.
142. Soilu-Hänninen, M., Salmi, S., & Salonen, R. (1995). Interferon-β downregulates expression of VLA-4 antigen and antagonizes interferon-γ-induced expression of HLA-DQ on human peripheral blood monocytes. J. Neuroimmunol. 60, 99-106.
143. Sommer, N., Loschmann, P. A., Northoff, G. H., Weller, M., Steinbrecher, A., Steinbach, J. P., Lichtenfels, R., Meyermann, R., Riethmuller, R., Fontana, A., Dichgans, J., & Martin, R. (1995). The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nature Med. 1, 244-248.
144. Spanaus, K-S., Nadal, D., Pfister, H-W., Seebach, J., Widmer, U., Frei, K., Gloor, S., & Fonatana, A. (1997). C-X-C and C-C chemoklines are expressed in the CSF in bacterial meningitis and mediate chemotactic activity on peripheral blood-derived polymorphonuclear and mononuclear cells in vitro. J. Immunol. 158, 1956-1964.
145. St. Pierre, B., Wong, J. L., & Merrill, J. E. (1996). Inhibition of human and rat glial cell function by antiinflammatory cytokines, antioxidants, and elevators of cAMP. In R. M. Devon, R. Doucette, B. H. J., Juurlink, A. J. Nazarali, D. J. Schreyer, & V. M. K. Verge (Eds.), Cell biology and pathology of myelin: Evolving biological concepts and therapeutic approaches, Plenum: New York.
146. Stadler, J., Harbecht, B. G., Di Silvio, M., Curran, R. D., Jordan, M. L., Simmons, R. L., & Billiar, T. R. (1993). Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J. Leukocyte Biol. 53, 165-172.
147. Stamler, J. S. (1994). Redox-signalling. Cell 78, 931-936.
148. 2. J. Exp. Med. 180, 2365-2370.
149. Svenningsson, A., Hansson, G. K., Andersen, O., Andersson, R., Patarroyo, M., & Stemme, S. (1993). Adhesion molecule expression on cerebrospinal fluid T lymphocytes: Evidence for common recruitment mechanisms in multiple sclerosis, asceptic meningitis, and normal controls. Ann. Neurol. 34, 155-161.
150. Tabuchi, A., Sano, K., Tsuchiya, T., & Tsuda, M. (1994). Modulation of AP-1 activity by nitric oxide in vitro. FEBS Lett. 351, 123-127.
151. Takahashi, G. W., Montgomery, R. B., Stahl, W. L., Crittenden, C. A., Valentine, M. A., Thorning, D. R., Andrews, F., & Lilly, M. B. (1994). Pentoxifylline inhibits tumor necrosis factor-a mediated cytotoxicity and cytostasis in L929 murine fibrosarcoma cells. Int. J. Immunopharmacol. 16, 723-736.
152. Tanaka, C., Kamata, H., Takeshita, H., Yagisawa, H., & Hirata, H. (1997). Redox regulation of LPS-induced IL-8 gene expression mediated by NF-κB and AP-1 in human astrocytoma U373 cells. Biochem. Biophys. Res. Commun. 232, 568-573.
153. Tazawa, R., Xu, X-M., Wu, K. K., & Wang, L-H. (1994). Characterization of the genomic structure, chromosomal location, and promoter of the human prostaglandin H synthase-2 gene. Biochem. Biophys. Res. Commun. 203, 190-199.
154. Tetsuka, T., Baier, L. D., & Morrison, A. R. (1996). Antioxidants inhibit interleukin-1-induced cyclooxygenase and nitric oxide synthase expression in rat mesangial cells. J. Biol. Chem. 271, 11689-11693.
155. Tian, L., & Lawrence, D. A. (1995). Lead induces nitric oxide production in vitro by murine spenic macrophages. Toxicol. Appl. Pharmacol. 132, 156-163.
156. Treppicchio, W. L., Bozza, M., Pedneault, G., & Dorner, A. J. (1996). Recombinant human IL-11 attenuates the inflammatory response through the down-regulation of the proinflammatory cytokine release and nitric oxide production. J. Immunol. 157, 3627-3634.
157. Vodovotz, Y., Bogdan, C., Paik, J., Xie, Q-W., & Nathan, C. (1993). Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor b. J. Exp. Med. 178, 605-613.
158. Vodovotz, Y., Kwon, N. S., Pospischil, M., Manning, J., Paik, J., & Nathan, C. (1994). Inactivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-γ and bacterial lipopolysacchardide. J. Immunol. 152, 4110-4118.
159. Willenborg, D. O., Stakova, M. A., & Miyasaka, M. (1996). Short term treatment with soluble neuroantigen and anti-CD11a (LFA-1) protects rats against autoimmune encephalomyelitis. J. Immunol. 157, 1973-1980.
160. Willenborg, D. O., Fordham, S. A., Cowden, W. B., & Ramshaw, I. A. (1995). Cytokines and murine autoimmune encephalomyelitis: Inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand. J. Immunol. 41, 31-41.
161. Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L., & Karin, N. (1992). Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 356, 63-66.
162. Zeiher, A. M., Fisslthaler, B., Schray-Utz, B., & Busse, R. (1995). Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ. Res. 76, 980-986.
163. Zhao, W., Tilton, R. G., Corbett, J. A., McDaniel, M. L., Misko, T. P., Williamson, J. R., Cross, A. H., & Hickey, W. F. (1996). Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J. Neuroimmunol. 64, 123-133.
164. Ziegler-Heitbrock, H. W. L., Sternsdorf, T., Liese, J., Belohradsky, B., Weber, C., Wedel, A., Schreck, R., Bäuerle, P., & Ströbel, M. (1993). Pyrrolidine dithiocarbamate inhibits NF-κB mobilization and TNF production in human monocytes. J. Immunol. 151, 6986-6993.
165. Zielasek, J., Jung, S., Gold, R., Liew, F. Y., Toyka, K. V., & Hartung, H-P. (1995). Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalitis. J. Neuroimmunol. 58, 81-88.